With FDA approval, Exact Sciences expects the new Cologuard Plus test to be available in 2025 for adults ages 45 and older ...

The FDA said on Monday it has authorized the first over-the-counter flu and COVID-19 combination test for the public to use ...

The prescription-free test you can take at home will help discern which respiratory virus you have, as symptoms often overlap ...

Cologuard Plus test, the company’s next-generation multi-target stool DNA test. The Cologuard Plus test is now approved for ...

The noninvasive test provides a beneficial screening tool for patients 45 and older at average risk for colorectal cancer.

FDA approves Exact Sciences' non-invasive Cologuard Plus test for colorectal cancer detection in adults at average risk.

Exact Sciences Corp. (NASDAQ: EXAS), a leading provider of cancer screening and diagnostic tests, today announced the U.S.

A single-arm phase II trial found that the use of lutetium (Lu)-177 dotatate (Lutathera) in patients with surgery- and ...

Exact Sciences’ next generation multitarget stool DNA test, Cologuard Plus test receives US FDA approval: Madison, Wisconsin Monday, October 7, 2024, 17:00 Hrs [IST] Exact Scien ...

Most of us have at least one good story reminding us that our mom knew something we should commit to memory — some lesson ...

A rapid decline in lung function is linked to the development of chronic obstructive pulmonary disease (COPD) ...

A test that uses cells from the inside of your cheek may accurately predict the risk of death within the upcoming year, new research hints. This study, published Oct. 1 in the journal Frontiers in ...